CSTF Stock Overview
Engages in the manufacturing, distribution, and sale of cannabis products under the JW Brands and Chad Enterprises brand names. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CuraScientific Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0012 |
| 52 Week Low | US$0.000001 |
| Beta | 1.83 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -99.89% |
| 33 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| CSTF | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 0% | 3.0% | 2.0% |
| 1Y | -99.9% | 12.8% | 32.4% |
Return vs Industry: CSTF underperformed the US Chemicals industry which returned 12.8% over the past year.
Return vs Market: CSTF underperformed the US Market which returned 32.4% over the past year.
Price Volatility
| CSTF volatility | |
|---|---|
| CSTF Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 5.4% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CSTF's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine CSTF's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2022 | 2 | Sam Berry | www.curascientificcorp.com |
CuraScientific Corp. engages in the manufacturing, distribution, and sale of cannabis products under the JW Brands and Chad Enterprises brand names. It offers cannabidiol, kava, and kratom. The company was formerly known as Boon Industries, Inc. and changed its name to CuraScientific Corp. in April 2023.
CuraScientific Corp. Fundamentals Summary
| CSTF fundamental statistics | |
|---|---|
| Market cap | US$5.53k |
| Earnings (TTM) | US$33.70m |
| Revenue (TTM) | US$1.05m |
0.0x
P/E Ratio0.0x
P/S RatioIs CSTF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CSTF income statement (TTM) | |
|---|---|
| Revenue | US$1.05m |
| Cost of Revenue | US$1.83m |
| Gross Profit | -US$775.05k |
| Other Expenses | -US$34.47m |
| Earnings | US$33.70m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0061 |
| Gross Margin | -73.65% |
| Net Profit Margin | 3,201.80% |
| Debt/Equity Ratio | -2.5% |
How did CSTF perform over the long term?
See historical performance and comparison